Risk of cardiovascular events after initiation of long-acting bronchodilators in patients with chronic obstructive lung disease: A population-based study

OBJECTIVES: Long-acting bronchodilators are mainstay treatment for moderate to severe chronic obstructive pulmonary disease. A growing body of evidence indicates an increased risk of cardiovascular events upon initiation of these medications. We hypothesize that this risk is higher in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljaafareh, Almotasembellah, Valle, Jose Ruben, Lin, Yu-Li, Kuo, Yong-Fang, Sharma, Gulshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052927/
https://www.ncbi.nlm.nih.gov/pubmed/27757229
http://dx.doi.org/10.1177/2050312116671337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052927/
https://www.ncbi.nlm.nih.gov/pubmed/27757229
http://dx.doi.org/10.1177/2050312116671337

Ejemplares similares